INmune Bio Inc. (INMB) PT Raised to $23 at Scotiabank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
INmune Bio Inc. (INMB) PT Raised to $23 at Raymond James
February 12, 2025 5:12 AM ESTRaymond James analyst Gary Nachman raised the price target on INmune Bio Inc. (NASDAQ: INMB) to $23.00 (from $18.00) while maintaining a Outperform rating.
The analyst comments "INMB announced a positive clinical/regulatory update and hosted an informative webcast for CORDStrom (MSC platform) for Recessive... More
